Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX

Carl Zeiss Meditec AG120 enrolled

Overview

It is planned to implant the intraocular lenses XL Stabi ZO and Invent ZO into the eyes of patients for whom a cataract operation is medically indicated. The lenses are marketed and CE certified. Their implantation is clinical routine. In the trial the accuracy of prediction of target refraction and the difference between calculated and measured contrast vision will be examined for both lens types.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

NONE

Enrollment

120

Conditions

Cataract

Interventions

Invent ZODEVICE

monofocal aspheric IOL for implantation into capsular bag

XL Stabi ZODEVICE

monofocal aspheric IOL for implantation into capsular bag

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Indication for cataract operation * Written informed consent of patient after information Exclusion Criteria: * Immobility * Limited capacity of understanding * Diseases that hamper a follow-up examination * Astigmatism \>2.0 D * Patients with ocular diseases who may be expected to show a vision of less than 0.63 (decimal) two months after cataract surgery with implantation of intraocular lens * Complications during surgery, especially complications with positioning of the intraocular lens and with capsulorhexis

Locations (1)

Universitäts-Augenklinik Mainz

Mainz, Germany

Outcomes

Primary Outcomes

Accuracy of prediction of target refraction

Time frame: postop.

Difference between calculated and measured contrast vision.

Time frame: postop.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.